Clinical Trials Directory

Trials / Conditions / Paget's Disease of Bone

Paget's Disease of Bone

7 registered clinical trials studyying Paget's Disease of Bone.

StatusTrialSponsorPhase
CompletedPathophysiology of Paget's Disease of Bone
NCT02802384
Johns Hopkins University—
CompletedEfficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (P
NCT00774020
Novartis PharmaceuticalsPhase 4
CompletedGenetic Study of Families Affected by Paget's Disease of Bone
NCT00747994
Assistance Publique - Hôpitaux de Paris—
CompletedSafety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Exte
NCT00103740
Novartis PharmaceuticalsPhase 3
Completed18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone
NCT00306046
Université Catholique de LouvainN/A
CompletedA Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETE
NCT00480662
Organon and CoPhase 3
CompletedSafety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Exte
NCT00051636
Novartis PharmaceuticalsPhase 3